3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
16
Radiotherapy
7
apatinib
5
anlotinib
3
Surgical Procedures, Operative
3
Chlorotoxin
3
Bevacizumab
3
Aminolevulinic Acid
3
Positron Emission Tomography Computed Tomography
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Irinotecan
2
Immunotherapy, Adoptive
2
Blood Specimen Collection
2
vandetanib
1
sodium thiosulfate
1
ribociclib
1
poly ICLC
1
lonafarnib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
etoposide phosphate
1
Vinblastine
1
Valproic Acid
1
Tranexamic Acid
1
Surveys and Questionnaires
1
Sunitinib
1
Rivaroxaban
1
Radiosurgery
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glioma
×
Eflornithine
×
Clear all
NCT02796261
2022-01-21
STELLAR
Orbus Therapeutics, Inc.
Phase 3
Unknown
343 enrolled